TRCT
LFST icon

Tower Research Capital (TRC)’s Lifestance Health LFST Stock Holding History

Tower Research Capital (TRC)’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.7K Sell
7,912
-3,098
-28% -$23.9K ﹤0.01% 2316
2026
Q1 		$70.1K Buy
11,010
+8,900
+422% +$61.9K ﹤0.01% 2462
2025
Q4 		$14.9K Sell
2,110
-2,773
-57% -$16.7K ﹤0.01% 3328
2025
Q3 		$26.9K Sell
4,883
-15,624
-76% -$76.6K ﹤0.01% 3048
2025
Q2 		$106K Buy
20,507
+16,893
+467% +$101K ﹤0.01% 2329
2025
Q1 		$24.1K Buy
3,614
+713
+25% +$5.42K ﹤0.01% 2796
2024
Q4 		$21.4K Sell
2,901
-9,316
-76% -$66.9K ﹤0.01% 3137
2024
Q3 		$85.5K Sell
12,217
-4,655
-28% -$28K ﹤0.01% 2344
2024
Q2 		$82.8K Buy
16,872
+15,088
+846% +$91K ﹤0.01% 2715
2024
Q1 		$11K Sell
1,784
-22,176
-93% -$149K ﹤0.01% 3616
2023
Q4 		$188K Buy
23,960
+21,657
+940% +$140K ﹤0.01% 2161
2023
Q3 		$15.8K Sell
2,303
-5,175
-69% -$41.9K ﹤0.01% 3592
2023
Q2 		$68.3K Buy
7,478
+5,003
+202% +$41.6K ﹤0.01% 2322
2023
Q1 		$18K Sell
2,475
-1,982
-44% -$11K ﹤0.01% 3563
2022
Q4 		$22K Sell
4,457
-2,262
-34% -$14K ﹤0.01% 3046
2022
Q3 		$45K Buy
6,719
+1,618
+32% +$11.3K ﹤0.01% 3258
2022
Q2 		$28K Buy
5,101
+4,258
+505% +$32.6K ﹤0.01% 3447
2022
Q1 		$9K Sell
843
-541
-39% -$4.75K ﹤0.01% 4465
2021
Q4 		$14K Buy
1,384
+1,034
+295% +$11K ﹤0.01% 4081
2021
Q3 		$5K Buy
350
+50
+17% +$963 ﹤0.01% 4866
2021
Q2 		$8K Buy
+300
New +$7.92K ﹤0.01% 4492

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Tower Research Capital (TRC)'s LFST Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Lifestance Health (LFST) stake by 28% in Q2 2026, selling an estimated $23.9K and leaving 7,912 shares worth $84.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

Tower Research Capital (TRC) first reported a position in LFST in Q2 2021 and has held it in 21 quarters since. The position peaked at $188K in Q4 2023. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Tower Research Capital (TRC) held 7,912 shares of Lifestance Health worth $84.7K as of Q2 2026.
  • Tower Research Capital (TRC) sold 3,098 Lifestance Health shares in Q2 2026, an estimated $23.9K.
  • Lifestance Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2316 holding.
  • Tower Research Capital (TRC) first reported a position in Lifestance Health in Q2 2021 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Lifestance Health position peaked at $188K in Q4 2023.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.